| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Immunology |
Departments of Human Genetics [N. R. d. S., D. R. H. d. B., E. K-B., A. G. v. K.], Tumor Immunology [R. T., M. W. J. S., G. J. A.], and Pathology [T. J. d. V., D. J. R., G. N. P. v. M.], University Hospital Nijmegen, 6500 HB Nijmegen, the Netherlands
The SSX genes, located on the X chromosome, encode a family of highly homologous nuclear proteins. The SSX1 and SSX2 genes were initially identified as fusion partners of the SYT gene in t(X;18)-positive synovial sarcomas. Recently, however, it was found that these two genes, as well as the highly homologous SSX4 and SSX5 genes, are aberrantly expressed in different types of cancers, including melanomas. Because normal SSX expression has been detected only in the testis and, at very low levels, the thyroid, these proteins are considered as new members of the still growing family of cancer/testis antigens. These antigens are presently considered as targets for the development of cancer immunotherapy protocols. In the present study, we developed a monoclonal antibody found to recognize SSX2, SSX3, and SSX4 proteins expressed in formaldehyde-fixed and paraffin-embedded tissues. This antibody was used to investigate SSX expression in normal testis and thyroid, benign melanocytic lesions, melanoma lesions, and melanoma cell lines. SSX nuclear expression in the testis was found to be restricted to spermatogenic cells, mainly spermatogonia. Of 18 melanoma cell lines analyzed, 9 showed SSX RNA and protein expression, although heterogeneously and at variable levels. Treatment of an SSX-negative cell line with 5-aza-2'-deoxycytidine, a demethylating agent, led to SSX RNA and protein expression, indicating a role for methylation in transcription regulation. Thirty-four of 101 primary and metastatic melanoma cases and 2 of 24 common nevocellular and atypical nevus cases showed SSX nuclear staining. Again, SSX expression was heterogeneous, ranging from widespread to scarce. Our findings stress the importance of assessing the a priori SSX expression status of melanoma cases that may be selected for immunotherapeutic trials.
This article has been cited by other articles:
|
|
 |
|
  C. Luo, X. Xiao, D. Liu, S. Chen, M. Li, A. Xu, J. Liu, S. Gao, S. Wu, and D. He CABYR Is a Novel Cancer-Testis Antigen in Lung Cancer Clin. Cancer Res., February 15, 2007; 13(4): 1288 - 1297. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H.-J. Heidebrecht, A. Claviez, M. L. Kruse, M. Pollmann, F. Buck, S. Harder, M. Tiemann, W. Dorffel, and R. Parwaresch Characterization and Expression of CT45 in Hodgkin's Lymphoma. Clin. Cancer Res., August 15, 2006; 12(16): 4804 - 4811. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M R Hussein, D A H Elsers, S A Fadel, and A-E M Omar Immunohistological characterisation of tumour infiltrating lymphocytes in melanocytic skin lesions. J. Clin. Pathol., March 1, 2006; 59(3): 316 - 324. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Neumann, C. Wagner, K.-D. Preuss, B. Kubuschok, C. Schormann, S. Stevanovic, and M. Pfreundschuh Identification of an epitope derived from the cancer testis antigen HOM-TES-14/SCP1 and presented by dendritic cells to circulating CD4+ T cells Blood, November 1, 2005; 106(9): 3105 - 3113. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Naka, S. Joyama, Y. Tsukamoto, K. Yoshioka, N. Hashimoto, T. Ujiiye, T. Hayashi, M. Kawase, M. Mano, S. Ishiguro, et al. Quantification of SSX mRNA Expression in Human Bone and Soft Tissue Tumors Using Nucleic Acid Sequence-Based Amplification J. Mol. Diagn., May 1, 2005; 7(2): 187 - 197. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Ayyoub, A. Merlo, C. S. Hesdorffer, D. Rimoldi, D. Speiser, J.-C. Cerottini, Y.-T. Chen, L. J. Old, S. Stevanovic, and D. Valmori CD4+ T Cell Responses to SSX-4 in Melanoma Patients J. Immunol., April 15, 2005; 174(8): 5092 - 5099. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Cronwright, K. Le Blanc, C. Gotherstrom, P. Darcy, M. Ehnman, and B. Brodin Cancer/Testis Antigen Expression in Human Mesenchymal Stem Cells: Down-regulation of SSX Impairs Cell Migration and Matrix Metalloproteinase 2 Expression Cancer Res., March 15, 2005; 65(6): 2207 - 2215. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Bricard, H. Bouzourene, O. Martinet, D. Rimoldi, N. Halkic, M. Gillet, P. Chaubert, H. R. MacDonald, P. Romero, J.-C. Cerottini, et al. Naturally Acquired MAGE-A10- and SSX-2-Specific CD8+ T Cell Responses in Patients with Hepatocellular Carcinoma J. Immunol., February 1, 2005; 174(3): 1709 - 1716. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Sigalotti, E. Fratta, S. Coral, S. Tanzarella, R. Danielli, F. Colizzi, E. Fonsatti, C. Traversari, M. Altomonte, and M. Maio Intratumor Heterogeneity of Cancer/Testis Antigens Expression in Human Cutaneous Melanoma Is Methylation-Regulated and Functionally Reverted by 5-Aza-2'-deoxycytidine Cancer Res., December 15, 2004; 64(24): 9167 - 9171. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Utsunomiya, H. Inoue, F. Tanaka, H. Yamaguchi, M. Ohta, M. Okamoto, K. Mimori, and M. Mori Expression of Cancer-Testis Antigen (CTA) Genes in Intrahepatic Cholangiocarcinoma Ann. Surg. Oncol., October 1, 2004; 11(10): 934 - 940. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Ebstein, C. Sapede, P.-J. Royer, M. Marcq, C. Ligeza-Poisson, I. Barbieux, L. Cellerin, G. Dabouis, and M. Gregoire Cytotoxic T Cell Responses against Mesothelioma by Apoptotic Cell-pulsed Dendritic Cells Am. J. Respir. Crit. Care Med., June 15, 2004; 169(12): 1322 - 1330. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Takeuchi, H. H. Q. Heng, C. J. Ye, S.-B. Liang, J. Iwata, H. Sonobe, and Y. Ohtsuki Down-Regulation of a Novel Actin-Binding Molecule, Skeletrophin, in Malignant Melanoma Am. J. Pathol., October 1, 2003; 163(4): 1395 - 1404. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Ayyoub, D. Rimoldi, P. Guillaume, P. Romero, J.-C. Cerottini, D. Valmori, and D. Speiser Tumor-reactive, SSX-2-specific CD8+ T Cells Are Selectively Expanded during Immune Responses to Antigen-expressing Tumors in Melanoma Patients Cancer Res., September 1, 2003; 63(17): 5601 - 5606. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Maio, S. Coral, L. Sigalotti, R. Elisei, C. Romei, G. Rossi, E. Cortini, F. Colizzi, G. Fenzi, M. Altomonte, et al. Analysis of Cancer/Testis Antigens in Sporadic Medullary Thyroid Carcinoma: Expression and Humoral Response to NY-ESO-1 J. Clin. Endocrinol. Metab., February 1, 2003; 88(2): 748 - 754. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Xie, B. Skytting, G. Nilsson, A. Gasbarri, K. Haslam, A. Bartolazzi, B. Brodin, N. Mandahl, and O. Larsson SYT-SSX Is Critical for Cyclin D1 Expression in Synovial Sarcoma Cells: A Gain of Function of the t(X;18)(p11.2;q11.2) Translocation Cancer Res., July 1, 2002; 62(13): 3861 - 3867. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Anne Westbrook, A. B. Diekman, S. Naaby-Hansen, S. A. Coonrod, K. L. Klotz, T. S. Thomas, E. J. Norton, C. J. Flickinger, and J. C. Herr Differential Nuclear Localization of the Cancer/Testis-Associated Protein, SPAN-X/CTp11, in Transfected Cells and in 50% of Human Spermatozoa Biol Reprod, January 1, 2001; 64(1): 345 - 358. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
